This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income countries annually by 2030 This marks ...
Building upon earlier discoveries continues to produce ever-better diabetes treatments. Molecules of insulin—a hormone that regulates blood glucose, or sugar—circulate in the blood stream, ensuring ...